Demonstrações financeiras detalhadas de Cellectis S.A. (CLLS): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
Cellectis S.A. registou receitas de $72.9M no último exercício, com um CAGR de 5 anos de 7.4%.
Margens dos últimos 12 meses: margem bruta 74.7%, margem operacional -107.9%, margem líquida -115.4%.
Ao preço atual de $1.38, CLLS apresenta lucros negativos (P/L não significativo) e um ROE de -94.14%. A capitalização de mercado é de $138M.
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $42.6M | $25.2M | $12.7M | $15.2M | $51.1M | $30.3M | $19.2M | $755000 | $41.5M | $72.9M |
| Custo da Receita | $1.7M | $2.6M | $2.7M | $11.4M | $2.0M | $1.8M | $8.5M | $7.4M | $9.2M | $9.8M |
| Lucro Bruto | $40.9M | $22.6M | $10.0M | $3.8M | $49.1M | $28.5M | $10.7M | -$6.7M | $32.3M | $63.2M |
| P&D | $74.6M | $79.2M | $76.6M | $92.0M | $77.0M | $117.8M | $97.5M | $87.6M | $90.5M | $93.5M |
| Despesas Gerais e Administrativas | $41.3M | $44.8M | $47.2M | $43.0M | $22.5M | $22.9M | $8.9M | $8.1M | $8.4M | $8.6M |
| Despesas Operacionais | $104.9M | $115.2M | $115.1M | $127.3M | $91.4M | $132.0M | $100.4M | $90.6M | $91.9M | $96.2M |
| Lucro Operacional | -$64.0M | -$92.7M | -$105.1M | -$123.6M | -$42.3M | -$103.5M | -$89.7M | -$97.3M | -$59.6M | -$33.1M |
| EBITDA | -$65.3M | -$108.1M | -$93.8M | -$105.7M | -$43.3M | -$78.4M | -$76.4M | -$92.6M | -$9.5M | -$39.8M |
| Despesas com Juros | $6310 | $560000 | $723000 | $3.0M | $3.7M | $4.2M | $3.8M | $5.3M | $7.5M | $8.1M |
| Lucro Antes de Impostos | -$63.9M | -$103.7M | -$88.3M | -$115.2M | -$53.6M | -$96.8M | -$98.6M | -$116.5M | -$36.8M | -$68.0M |
| Imposto | -$1.5M | -$13.2M | 0 | 0 | 0 | -$3000 | $87000 | $371000 | 0 | -$423000 |
| Lucro Líquido | -$63.9M | -$99.4M | -$78.7M | -$102.1M | -$81.1M | -$114.2M | -$106.1M | -$101.1M | -$36.8M | -$67.6M |
| LPA | $-1.81 | $-2.78 | $-1.93 | $-2.14 | $-1.71 | $-2.69 | $-2.33 | $-1.77 | $-0.41 | $-0.68 |
| LPA Diluído | $-1.78 | $-2.78 | $-1.93 | $-2.14 | $-1.71 | $-2.69 | $-2.33 | $-1.77 | $-0.41 | $-0.68 |
| Ações em Circulação (Diluídas) | $35.8M | $35.7M | $40.8M | $42.4M | $42.5M | $42.4M | $45.6M | $57.0M | $90.6M | $100.3M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $35.2M | $10.4M | $5.8M | $5.2M |
| Lucro Bruto | $32.8M | $7.4M | $1.2M | $815868 |
| Lucro Operacional | $8.0M | -$17.4M | -$27.1M | -$25.5M |
| EBITDA | $7.7M | -$19.6M | -$22.5M | -$21.0M |
| Lucro Líquido | $589000 | -$26.3M | -$17.8M | -$21.8M |
| LPA | $0.01 | $-0.27 | $-0.18 | $-0.22 |
| LPA Diluído | $0.01 | $-0.27 | $-0.18 | $-0.22 |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $290.5M | $297.0M | $451.9M | $360.9M | $241.1M | $185.6M | $89.8M | $136.7M | $143.3M | $63.6M |
| Investimentos de Curto Prazo | 0 | 0 | 0 | 0 | $27.1M | $499000 | $7.9M | $67.1M | $117.1M | $145.1M |
| Contas a Receber | $3.6M | $4.6M | $22.1M | $15.3M | $19.2M | $31.1M | $17.6M | $23.1M | $23.0M | $25.3M |
| Estoque | $117790 | $250000 | $275000 | $2.9M | $1.6M | 0 | 0 | 0 | 0 | 0 |
| Ativos Circulantes | $311.8M | $323.2M | $487.6M | $391.5M | $315.4M | $225.4M | $143.8M | $233.0M | $287.1M | $236.2M |
| Imobilizado | $16.9M | $7.2M | $10.0M | $69.3M | $145.5M | $148.3M | $107.9M | $92.7M | $75.9M | $62.4M |
| Ágio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Intangíveis | $1.3M | $1.4M | $1.3M | $1.1M | $1.6M | $1.9M | $718000 | $672000 | $1.1M | $535000 |
| Ativos Totais | $330.7M | $332.9M | $500.8M | $467.5M | $469.5M | $382.1M | $261.2M | $334.3M | $383.5M | $324.7M |
| Contas a Pagar | $9.7M | $9.5M | $15.9M | $29.3M | $24.6M | $23.8M | $21.5M | $19.1M | $18.7M | $17.3M |
| Dívida de Curto Prazo | $1.7M | 0 | 0 | 0 | 0 | $2.2M | $5.0M | $5.2M | $4.8M | $18.2M |
| Passivos Circulantes | $56.0M | $43.5M | $46.9M | $62.6M | $52.0M | $49.3M | $63.0M | $155.1M | $166.3M | $145.8M |
| Dívida de Longo Prazo | 0 | 0 | 0 | 0 | $24.2M | $18.8M | $13.6M | $28.4M | $44.0M | $74.0M |
| Passivos Totais | $56.6M | $47.0M | $50.6M | $112.0M | $160.6M | $145.6M | $135.3M | $249.6M | $252.5M | $248.8M |
| Reservas | -$229.8M | -$351.3M | -$405.3M | -$508.5M | -$587.0M | -$698.3M | -$439.5M | -$405.8M | -$329.6M | -$334.1M |
| Patrimônio Líquido | $272.2M | $266.8M | $409.3M | $315.1M | $283.8M | $221.3M | $118.0M | $84.7M | $131.0M | $75.9M |
| Dívida Total | $1.8M | $34000 | $1.4M | $47.6M | $106.7M | $100.9M | $75.8M | $85.1M | $91.5M | $119.9M |
| Dívida Líquida | -$288.7M | -$296.9M | -$450.5M | -$313.3M | -$161.6M | -$85.3M | -$21.9M | -$118.8M | -$168.8M | -$88.8M |
| Capital de Giro | $255.7M | $279.7M | $440.8M | $328.9M | $263.3M | $176.1M | $80.8M | $77.9M | $120.8M | $90.5M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $52.2M | $63.6M | $35.0M | $35.6M |
| Ativos Totais | $343.0M | $324.7M | $289.2M | $267.4M |
| Passivos Totais | $242.6M | $248.8M | $229.3M | $226.3M |
| Patrimônio Líquido | $100.5M | $75.9M | $59.9M | $41.1M |
| Dívida Total | $92.8M | $119.9M | $108.6M | $84.6M |
Fluxo de Caixa (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | -$63.9M | -$103.7M | -$88.3M | -$115.2M | -$53.6M | -$96.7M | -$98.7M | -$116.8M | -$36.7M | -$67.8M |
| Depreciação e Amortização | $2.1M | $3.4M | $2.4M | $6.9M | $7.8M | $14.2M | $18.4M | $18.5M | $19.8M | $20.1M |
| Compensação em Ações | $55.7M | $50.4M | $37.2M | $26.9M | $10.0M | $11.5M | $6.0M | $5.2M | 0 | 0 |
| Variação Capital de Giro | -$24.9M | -$17.8M | -$9.1M | $11.7M | -$17.3M | -$12.3M | -$5.7M | -$4.0M | $53.6M | -$41.7M |
| Fluxo de Caixa Operacional | -$31.1M | -$52.3M | -$68.1M | -$69.1M | -$80.3M | -$104.6M | -$87.4M | -$24.7M | $22.1M | -$40.1M |
| CapEx | -$13.3M | -$2.7M | -$4.9M | -$13.0M | -$44.4M | -$18.6M | -$2.4M | -$1.1M | -$2.6M | -$2.4M |
| Aquisições | -$298683 | $7.2M | $1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Ações | -$137000 | 0 | 0 | -$469000 | 0 | 0 | -$569000 | 0 | 0 | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | -$44.4M | -$55.0M | -$73.0M | -$82.1M | -$124.7M | -$123.1M | -$89.9M | -$25.8M | $19.5M | -$42.5M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | -$1.6M | -$10.5M | -$15.6M | -$14.3M |
| CapEx | -$1.2M | -$478569 | -$265966 | -$253000 |
| Fluxo de Caixa Livre | -$2.8M | -$11.0M | -$15.8M | -$14.5M |
| Dividendos Pagos | 0 | 0 | 0 | 0 |
| Compensação em Ações | 0 | 0 | 0 | $2.3M |
Crescimento e Margens (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | -40.9% | -49.5% | +19.3% | +236.1% | -40.6% | -36.8% | -96.1% | +5397.5% | +75.8% |
| Crescimento Lucro Líquido (anual) | | -55.5% | +20.8% | -29.7% | +20.6% | -40.9% | +7.1% | +4.8% | +63.6% | -83.9% |
| Crescimento LPA (anual) | | -53.6% | +30.6% | -10.9% | +20.1% | -57.3% | +13.4% | +24.0% | +76.8% | -65.9% |
| Variação de Ações (anual) | | -0.3% | +14.2% | +4.1% | +0.1% | -0.1% | +7.3% | +25.2% | +58.9% | +10.7% |
| Crescimento FCF (anual) | | -23.8% | -32.8% | -12.4% | -51.9% | +1.3% | +27.0% | +71.3% | +175.6% | -317.7% |
| Margem Bruta | 96.0% | 89.6% | 78.5% | 25.0% | 96.2% | 93.9% | 55.7% | -882.6% | 77.9% | 86.6% |
| Margem Operacional | -150.2% | -367.8% | -825.5% | -813.4% | -82.9% | -341.0% | -467.7% | -12887.7% | -143.5% | -45.3% |
| Margem EBITDA | -153.4% | -429.1% | -736.7% | -696.1% | -84.9% | -258.4% | -398.4% | -12269.8% | -22.8% | -54.6% |
| Margem Líquida | -150.1% | -394.5% | -618.1% | -672.1% | -158.8% | -376.3% | -553.6% | -13385.3% | -88.6% | -92.7% |
| Margem FCF | -104.3% | -218.3% | -573.6% | -540.5% | -244.2% | -405.7% | -468.9% | -3419.7% | 47.0% | -58.3% |
| Taxa Efetiva de Imposto | 2.4% | 12.7% | -0.0% | -0.0% | -0.0% | 0.0% | -0.1% | -0.3% | -0.0% | 0.6% |
Dados por Ação (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $-1.24 | $-1.54 | $-1.79 | $-1.93 | $-2.93 | $-2.90 | $-1.97 | $-0.45 | $0.22 | $-0.42 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $35.3M | $35.7M | $40.8M | $42.4M | $42.5M | $42.4M | $45.6M | $57.0M | $90.6M | $100.3M |
O que olhar em Biotech
A maioria das biotechs pequenas perde dinheiro. Analisar com P/E não faz sentido — olha caixa e pipeline.
- Cash Runway — Meses de caixa ao ritmo atual de gasto. <18 meses = risco de diluição urgente
- Cash burn anual — Ritmo a que queimam caixa operacional. Comparar com posição de caixa para projetar runway
- Dívida Total — Biotech sem receita + dívida = receita para falência
- I+D / Capitalização — Quanto investem em pipeline vs valor da empresa — indicador de intensidade de pesquisa
- Market cap / Caixa — Se cota perto do caixa, o mercado dá ~0 valor ao pipeline — oportunidade ou armadilha
Rentabilidade
| Retorno sobre patrimônio | -94.14% |
| Retorno sobre capital investido | -41.00% |
| Retorno sobre ativos | -24.41% |
| Margem bruta | 74.68% |
| Margem operacional | -107.92% |
| Margem líquida | -115.36% |
Saúde financeira
| Dívida / Patrimônio | 2.06 |
| Liquidez corrente | 1.37 |
Índices Chave (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | -9.36 | -10.82 | -8.63 | -8.00 | -15.82 | -3.02 | -0.90 | -1.74 | -4.39 | -7.12 |
| P/VP | 2.20 | 4.03 | 1.66 | 2.31 | 4.05 | 1.56 | 0.81 | 2.07 | 1.24 | 6.39 |
| P/V | 14.05 | 42.64 | 53.32 | 47.83 | 22.53 | 11.36 | 4.99 | 232.58 | 3.93 | 6.65 |
| Margem Bruta | 96.0% | 89.6% | 78.5% | 25.0% | 96.2% | 93.9% | 55.7% | -882.6% | 77.9% | 86.6% |
| Margem Operacional | -150.2% | -367.8% | -825.5% | -813.4% | -82.9% | -341.0% | -467.7% | -12887.7% | -143.5% | -45.3% |
| Margem Líquida | -150.1% | -394.5% | -618.1% | -672.1% | -158.8% | -376.3% | -553.6% | -13385.3% | -88.6% | -92.7% |